ClinicalTrials.Veeva

Menu

Novosyn® Quick in Patients Undergoing Episiotomy Closure (RETRO-EPINOQ)

Aesculap logo

Aesculap

Status

Enrolling

Conditions

Episiotomy Wound

Treatments

Procedure: Episiotomy Closure

Study type

Observational

Funder types

Industry

Identifiers

NCT05233527
AAG-O-H-2111

Details and patient eligibility

About

Retrospective, monocentric clinical study on the clinical performance of Novosyn® Quick in patients undergoing episiotomy closure.

Full description

The study design is a retrospective, consecutive series of women with a spontaneous vaginal delivery who required an indicated episiotomy with Novosyn® Quick between the period January 2020 - December 2020 at Hospital General de Catalunya.

All women treated with Novosyn® Quick between January 2020 - December 2020 at the Hospital General de Catalunya will be analyzed. The investigator team will access medical records for the cohort of patients identified.

Enrollment

300 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women who underwent an indicated episiotomy between January 2020 - December 2020 at the Hospital General de Catalunya (Sant Cugat del Vallès, Spain) and received Novosyn® Quick

Exclusion criteria

  • No exclusion criteria have been set

Trial contacts and locations

1

Loading...

Central trial contact

Jaume García López; Ricard Rosique Jové

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems